HIV感染与循环中前表面活性蛋白B及表面活性蛋白D水平
该研究在500例HIV感染者和300例HIV未感染者注射吸毒者中估计前表面活性蛋白B(pro-SFTPB)和表面活性蛋白D(SFTPD)的几何均值,并调整吸烟等协变量。SFTPD未见这些关联。
要点
- HIV感染者血清pro-SFTPB水平显著高于未感染者。
- pro-SFTPB升高与CD4降低、HIV RNA升高及未用HAART相关。
- SFTPD水平与HIV感染及免疫抑制指标无显著关联。
核心结论
- HIV感染者血清pro-SFTPB水平升高,且与免疫抑制和病毒血症未控制相关。
研究设计与样本
- 在500例HIV感染者和300例HIV未感染者注射吸毒者中估计pro-SFTPB和SFTPD的几何均值,并调整吸烟及其他协变量。
主要发现
- SFTPD未观察到上述关联。
临床怎么用
- pro-SFTPB可作为反映HIV感染者肺损伤及免疫抑制状态的潜在血清标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prosurfactant protein B (pro-SFTPB) and surfactant protein D (SFTPD) are markers of lung inflammation and damage. We estimated geometric mean pro-SFTPB and SFTPD levels in 500 human immunodeficiency virus (HIV)-infected and 300 HIV-uninfected injection drug users, adjusting for smoking and other covariates. Pro-SFTPB levels were significantly higher among people with HIV (PWH) (adjusted geometric mean, 21.4 vs 18.1 ng/mL; P = .03), and were higher with lower CD4 counts (P trend = .001), higher HIV RNA (P trend = .05), and without highly active antiretroviral therapy (P = .03). These associations were not observed for SFTPD. Serum levels of pro-SFTPB are elevated among PWH and are associated with immunosuppression and uncontrolled viremia.
引用
- Shiels MS, Kirk GD, Drummond MB, et al. HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D. J Infect Dis. 2018. PMID: 29272472. doi:10.1093/infdis/jix510
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。